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From the aerial parts of Helichrysum chasmolycicum P.H Davis, which is an endemic species in Turkey, the flavonoids apigenin, luteolin,
kaempferol, 3,5-dihydroxy-6,7,8-trimethoxyflavone, 3,5-dihydroxy-6,7,8,4′-tetramethoxyflavone, apigenin 7-O-glucoside, apigenin 4′-O-gluco-
side, luteolin 4′-O-glucoside, luteolin 4′,7-O-diglucoside, kaempferol 3-O-glucoside, kaempferol 7-O-glucoside and quercetin 3-O-glucoside were
isolated. The methanol extract of the aerial parts of H. chasmolycicum showed antioxidant activity by DPPH method (IC50 0.92 mg/mL).
Antimicrobial activity test was performed on the B, D, E extracts and also 3,5-dihydroxy-6,7,8-trimethoxyflavone and kaempferol 3-O-glucoside
which were the major flavonoid compounds obtained from aerial parts of H. chasmolycicum by microbroth dilutions technique. The E (ethanol–
ethyl acetate) extract showed moderate antimicrobial activity against Pseudomonas aeruginosa, B (petroleum ether–60% ethanol-chloroform)
extract and 3,5-dihydroxy-6,7,8-trimethoxyflavone showed moderate antifungal activity against Candida albicans.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Flavonoids; Antioxidant ativity; Antimicrobial activity; Helichrysum chasmolycicum; 3,5-dihydroxy-6,7,8-trimethoxyflavone1. Introduction
Helichrysum Gaertner (Asteraceae) is a very large genus
consisting of approximately 500 species in the world (Engler,
1964). The Helichrysum species are also found in southern
Europe, south-west Asia, southern India, Sri Lanka and
Australia, most species occur in Africa, including Madagascar
(Lourens et al., 2008). In Turkey, the genus Helichrysum is
represented by 26 taxa belonging to 20 species in Turkish flora
of which 14 are endemic to Turkey (Davis, 1975; Davis et al.,
1988; Erik, 2000; Kupicha, 1975).
Species from the genus Helichrysum are widely used as
traditional medicine to cure various ailments (Hutchings and
Van Staden, 1994; Lourens et al., 2008; Sezik et al., 2001). It is
given in Dioscorides records, Materia Medica that the heads of
H. siculum (H. stoechas subsp. barrelieri) are used to cure
biliousness. In Turkey, several Helichrysum spp. are used in⁎ Corresponding author. Tel.: +90 0212 4400000; fax: +90 0212 4400252.
E-mail address: sevdasuzgec@hotmail.com (S. Süzgeç-Selçuk).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2010.07.017folk medicine for removing the kidney stones and as diuretics.
The diuretic and bile regulatory effects of the Helichrysum spp.
are due to the flavonoids they contain (Çubukçu, 2002).
Various biological activities of the members of this genus
were reported elsewhere; choleretic (Delapuerta et al., 1993),
chologogue (Çubukçu, 2002), antimicrobial (Meyer and
Afolayan, 1995), antimalarial (Van Vuuren et al., 2006),
antioxidant, antidiabetic (Aslan et al., 2007), antiinflammatory
(Jäger et al., 1996), antiproliferative (Yagura et al., 2008),
antiviral and antituberculous (Lall et al., 2006).
The chemistry of Helichrysum genus is complex with a wide
variety of chemical classes which are flavonoids, chalcones,
phloroglucinol derivatives, essential oils, α-pyrones and
diterpenes (Jakupovic et al., 1986; Lourens et al., 2008).
Increasingly, flavonoids are becoming the subject of
medicinal research. In the Department of Pharmacognosy of
Istanbul University, investigations are in process dealing with
the Anatolian Helichrysum spp., especially on their flavonoids
(Çubukçu and Bingöl, 1984; Çubukçu and Meriçli, 1977;
Çubukçu and Yüksel, 1982; Meriçli et al., 1984; Süzgeç et al.,ts reserved.
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flavonoid composition of H. chasmolycicum. Only the compo-
sition of the essential oil of H. chasmolycicum has been studied
previously (Chalchat and Özcan, 2006).
Flavonoid-rich plant extracts of Helichrysum species have
been reported to possess antimicrobial and antioxidant activity
(Albayrak et al., 2010; Cushnie and Lamb, 2005). However, the
compounds responsible for the antimicrobial activity have been
identified only in a few cases. In this work, we investigated for
the first time the flavonoid compounds from H. chasmolycicum
which is an endemic species and evaluated its antioxidant and
antimicrobial activities. Also antimicrobial activity tests were
performed on the main flavonoid compounds which were
isolated from petroleum ether–60% ethanol-chloroform (B)
extract and ethanol–ethyl acetate (E) extract. In addition, the
results were compared with other Anatolian Helichrysum
species.
2. Materials and methods
2.1. Plant material
H. chasmolycicum P.H. Davis (Asteraceae), aerial parts were
collected on Dedegül Mountain, Isparta-Aksu, Turkey in
August 1997 and identified by Professor Hasan Özçelik. A
voucher specimen was deposited in the Herbarium of the
Faculty of Science and Literature, Süleyman Demirel Univer-
sity (No: Özçelik 7838), Isparta, Turkey.
2.2. General experimental procedures
The UV spectra were measured on a Shimadzu UV-1601
spectrophotometer in MeOH. 1H NMR spectra were recorded
on a Bruker 500 MHz spectrophotometer using CDCl3 as a
solvent. Paper chromatography (PC) were applied on Whatman
No. 1. For preparative TLC, silica gel 60 F254 plates (0.25 mm,
Merck) were used. For column chromatography silica gel 60
(0.063–0.200 mm; Merck) (0.2–0.5 mm; Merck), polyamide 6
(Fluka Chemical) and Sephadex LH-20 (Sigma-Aldrich) were
used. For antioxidant activity 2,2-Diphenyl-1-picrylhydrazyl
and ascorbic acid were purchased from Fluka Chemical. All
other chemicals used were of analytical grade.
2.3. Extraction and isolation of flavonoid compounds
The dried aerial parts (500 g) of H. chasmolycicum was first
extracted with petroleum ether and then with EtOH (95%) in a
Soxhlet apparatus. The petroleum ether extract was concentrat-
ed (A) (yield 3.36 %) and extracted with 60% ethanol. The
60% ethanol extract was concentrated and extracted with
chloroform (B) (yield 2.05 %). The concentrated 95% EtOH
extract was diluted with H2O and extracted with toluene (C)
(yield 1.87 %), chloroform (D) (yield 1.53 %) and ethyl acetate
(E) (yield 2.17 %) successively for fractionation. A qualitative
evaluation of the extracts by TLC and PC were performed in
order to select the extracts which are rich in flavonoids. For
TLC, solvent systems toluene:ethyl acetate:formic acid (5:4:1),benzene:diethyl ether:dichloromethane (1:1:1), ethyl acetate:
ethyl methyl ketone:formic acid:water (5:3:1:1), benzene:
ethanol (2:1), benzene:acetone (8:2) and for PC: butanol:acetic
acid:water (4:1:5), acetic acid:water (60:40), acetic acid:water:
conc.HCl (30:10:3), butanol:acetic acid:water (3:1:1), acetic
acid:water (15:85) were used. Thus the extract B, D and E were
selected to be investigated for their flavonoids. The extract B
and D were chromatographed over silica gel. The extract E were
chromatographed over silica gel and polyamide columns.
Fractions were collected in 40 mL volumes and combined
according to TLC analysis.
The extract B (2 g) was separated on a column of silica gel
eluting with toluene:acetone (100:0, 98:2, 97:3, 96:4, 95:5,
90:10, 80:20). From combined fraction 15–18 (224 mg)
(toluene:acetone—96:4), 3,5-dihydroxy-6,7,8-trimethoxyfla-
vone (15 mg) was isolated using preparative TLC developed
with benzene:acetone (8:2). From combined fraction 19–22
(91 mg) (toluene:acetone—95:5) and fraction 23–31 (164 mg)
(toluene:acetone—95:5), 3,5-dihydroxy-6,7,8,4′-tetramethox-
yflavone (7 mg) was isolated using preparative TLC developed
with petroleum ether:chloroform:methanol (7:4:1).
The extract D (1.5 g) was separated on a column of silica gel
eluting with toluene:acetone (from 7:1 to 1:1 gradually). From
combined fraction 8–9 (12 mg) (toluene:acetone—7:1), kaemp-
ferol (3 mg) was isolated using preparative TLC developed with
benzene:acetone (8:2). From combined fraction 10–11 (36 mg)
(toluene:acetone—6:1), and 12–13 (9 mg) (toluene:acetone—
6:1), apigenin (6 mg) was isolated using preparative TLC
developed with benzene:ethanol (8:2). From combined fraction
29–40 (79 mg) (toluene:acetone—4:1) and 41–47 (25 mg)
(toluene:acetone—4:1), luteolin (5 mg) was isolated using
preparative PC developed with acetic acid:water (40:60).
The extract E was separated on a column of silica gel eluting
with toluene:acetone (from 7:1 to 1:1 gradually) and on a column
of polyamide eluting with distilled water:methanol (100:0, 90:10,
80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, 0:100).
For each column 1 g of extract E was used. From fraction 82
(72 mg) (toluene:acetone—50:50), apigenin 7-O-glucoside
(7 mg) and kaempferol 3-O-glucoside (astragalin) (15 mg) were
isolated using preparative TLC developed with benzene: ethanol
(2:1). From combined fraction 82–90 (60 mg) (water:methanol—
60:40), apigenin 4′-O-glucoside (6 mg) was isolated using
preparative TLC developed with benzene:ethanol (2:1). From
combined fraction 91–97 (62 mg) (water:methanol—60:40),
quercetin 3-O-glucoside (10 mg) and kaempferol 7-O-glucoside
(6 mg) were isolated using preparative TLC developed with
benzene:ethanol (2:1). From combined fraction 98–103 (27 mg)
(water:methanol—60:40) and fraction 104–109 (21 mg) (water:
methanol—50:50), luteolin 4′,7-O-diglucoside (7 mg) and luteo-
lin 4′-O-glucoside (6 mg) were isolated using preparative
TLC developed with benzene:ethanol (2:1). Further repeated
purification over Sephadex LH-20, eluting with methanol for all
flavonoid glucoside compounds.
The glycosides were subjected to acid hydrolysis. The
structures of the pure compounds were elucidated by Rf values,
colour reactions and spectroscopic methods (UV, 1H NMR) on
comparison with authentic samples and with their data
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Mambry et al., 1970). Twelve compounds which were isolated
and identified from H. chasmolycicum were all known
compounds. The flavonoids 3,5-dihydroxy-6,7,8-trimethoxy-
flavone (12 mg), 3,5-dihydroxy-6,7,8,4′-tetramethoxyflavone
(7 mg) were isolated from extract B; apigenin (6 mg), luteolin
(5 mg) kaempferol (3 mg) were isolated from extract D;
apigenin 7-O-glucoside (7 mg), apigenin 4′-O-glucoside
(6 mg), luteolin 4′-O-glucoside (6 mg), luteolin 4′,7-O-diglu-
coside (7 mg), kaempferol 3-O-glucoside (15 mg), kaempferol
7-O-glucoside (6 mg), quercetin 3-O-glucoside (10 mg) were
isolated from extracts E.2.3.1. Acid hydrolsis and sugar analysis
Glycoside was mixed with 6 % aqueous hydrochloric acid
(5 mL) using a minimum of methanol to effect complete
solution. The solution was heated at 110 °C on a steam bath for
6 h and then cooled and extracted thoroughly by shaking with
ether. Evaporation of the aqueous layer yielded glucose. PC was
used to identify sugars by comparison of the Rf values with
authentical samples. For PC solvent systems ethyl acetate:
pyridine:water (12:5:4) and butanol:acetic acid:water (4:1:5)
were used.2.4. DPPH radical-scavenging activity
The antioxidant activity test was performed on the extract
obtained from the aerial parts of H. chasmolycicum (1 g) using
methanol (100 mL) in Soxhlet apparatus for 8 h. The assay was
done according to the DPPH assay (Blois, 1958; Suja et al.,
2005).
Extract solution (0.1 mL) in methanol at different concentra-
tions (1–0.61 mg/mL) was added to 3.9 mL of methanol solution
(0.025 g/lt) of DPPH. The mixture was shaken vigorously and
allowed to stand in the dark at room temperature for 30 min. The
decrease in absorbance of the resulting solution was then
measured spectrophotometrically at 515 nm against methanol.
All measurements were made in triplicate and averaged. Two
controls were used for this test, a negative control (containing all
reagents except the test sample) and positive controls using the
reference antioxidant as ascorbic acid (1–0.61 mg/mL) for
comparison. The ability to scavenge DPPH radical was calculated
by the following equation:
Inhibition % = AC 0ð Þ–AA tð Þð Þ = AC 0ð Þ½  × 100
AC 0ð Þ = Absorbance of the control at 515 nm t = 0
AA tð Þ = Absorbance of the sample t = 30 min:
The antioxidant activity of the methanol extract from aerial
parts of H. chasmolycicum was expressed as IC50. The IC50
value was defined as the concentration (in mg/mL) of the extract
that inhibit the formation of DPPH radicals by 50%. The IC50
value was calculated from the data obtained using GraphPad
Prism software. The DPPH assay was repeated four times for
each concentration.2.5. Antimicrobial activitiy
Antimicrobial activity test was performed on the B, D, E
extracts obtained from aerial parts of H. chasmolycicum and
also on the pure compounds 3,5-dihydroxy-6,7,8-trimethoxy-
flavone and kaempferol 3-O-glucoside.
Antimicrobial activity against Staphylococcus aureus ATCC
6538, Escherichia coli ATCC 25922, Klebsiella pneumoniae
ATCC 4352, Pseudomonas aeruginosa ATCC 27853, Proteus
mirabilis ATCC 14153 and Candida albicans ATCC 10231
were determined by the microbroth dilutions technique using
the Clinical Laboratory Standards Institute (CLSI) recommen-
dations (CLSI, 2002, 2006). Mueller–Hinton broth for bacteria,
RPMI-1640 medium buffered to pH 7.0 with MOPS for yeast
strain were used as the test medium. Serial two-fold dilutions
ranging from 5000 μg/mL to 4.9 μg/mL were prepared in
medium. The inoculum was prepared using a 4–6 h broth
culture of each bacteria and 24 h culture of yeast strains adjusted
to a turbidity equivalent to a 0.5 McFarland standard, diluted in
broth media to give a final concentration of 5×105 cfu/mL for
bacteria and 0.5×103 to 2.5×103 cfu/mL for yeast in the test
tray. The trays were covered and placed in plastic bags to
prevent evaporation. The trays containing Mueller–Hinton
broth were incubated at 35 °C for 18–20 h and the trays
containing RPMI-1640 medium were incubated at 35 °C for
46–50 h. The MIC was defined as the lowest concentration of
compound giving complete inhibition of visible growth. As
control, antimicrobial effects of the solvents were investigated
against test microorganisms. According to values of the
controls, the results were evaluated. All the microorganisms
were obtained from American Type Culture Collection
(ATCC), Manassas (VA), USA.
Ciprofloxacin was used as positive control for tested bacteria
whereas fluconazole was used as positive control for yeast.
Each treatment was replicated three times.3. Results and discussion
Twelve known flavonoids were isolated from the aerial parts
of H. chasmolycicum and shown in Table 1. H. chasmolycicum
flavonoid content has been found different from the other
Anatolian Helichrysum species in comparison. The helichry-
sins, characteristic Helichrysum flavonoids, were not detected
in this species. The flavonoid composition of H. chasmolycicum
appears to be similar to H. compactum in their major flavonoids
(3,5-dihydroxy-6,7,8-trimethoxyflavone, kaempferol 3-O-glu-
coside) (Süzgeç et al., 2005).
The results from this study are in accordance with previous
biological activity reports on the genus Helichrysum (Albayrak
et al., 2010; Cushnie and Lamb, 2005). The compounds
responsible for the antimicrobial and antioxidant activity of H.
chasmolycicum are possibly the flavonoids found in the aerial
parts.
The methanol extract of aerial parts of H. chasmolycicum
possessed DPPH radical-scavenging activity with an IC50 value
of 0.92 mg/mL.
Table 1
The flavonoid compounds isolated from aerial parts of H. chasmolycicum.
Flavonoid compounds Extracts Flavonoid amounts (mg)
Apigenin D 6
Luteolin D 5
Kaempferol D 3
3,5-dihydroxy-6,7,8-trimethoxyflavone B 12
3,5-dihydroxy-6,7,8,4′-
tetramethoxyflavone
B 7
Apigenin 7-O-glucoside E 7
Apigenin 4′-O-glucoside E 6
Luteolin 4′-O-glucoside E 6
Luteolin 4′,7-O-diglucoside E 7
Kaempferol 3-O-glucoside E 15
Kaempferol 7-O-glucoside E 6
Quercetin 3-O-glucoside E 10
Extracts: B (petroleum ether–60% ethanol-chloroform extract); D (ethanol-
chloroform extract); E (ethanol–ethyl acetate extract).
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extracts of 16 Helichrysum species collected from Turkey were
investigated for their antioxidant activity by DPPH method and
also antimicrobial activities except H. chasmolycicum. When
compared with the antioxidant activity results which were done
according to DPPH method, the other Helichrysum species
showed more activity than H. chasmolycicum.
The key role of phenolic compounds as scavengers of free
radicals is emphasized in several reports (Ćetković et al., 2008;
Hernández et al., 2009). The main phenolic compounds of the
genus Helichrysum are flavonoids which have remarkable
antioxidant activity (Czinner et al., 2000). Based on this report,
antioxidant potential of the extract studied here could be
attributed to flavonoids.
The antimicrobial activity results are shown in Table 2. The
antimicrobial activity of extracts from Helichrysum species
have been widely reported (Coşar and Çubukçu, 1990; Meyer
and Afolayan, 1995; Rios et al., 1991; Tomas-Barberan et al.,
1990). The antibacterial activity has been demonstrated for a
number of Helichrysum species as H. armenium subsp.Table 2
Antimicrobial activities (MIC in μg/mL) of H. chasmolycicum flavonoid
extracts and compounds.
Tested material Microorganisms
S.a. E.c. K.p. P.a. P.m. C.a.
Extract B – – – – – 312
Extract D – – – – – –
Extract E – – – 625 – –
3,5-dihydroxy-6,7,8-
trimethoxyflavone
– – – – – 312
Kaempferol 3-O-glucoside – – – – – –
Ciprofloxacin 0.25 0.625 0.625 0.5 0.312 nt
Fluconazole nt nt nt nt nt 1
S.a., Staphylococcus aureus; E.c., Escherichia coli; K.p., Klebsiella pneumo-
niae; P.a., Pseudomonas aeruginosa; P.m., Proteus mirabilis; C.a., Candida
albicans.
MIC: miniumum inhibitory concentration.
(–): not active.
(nt): not tested.armenium, H. pallasii, H. graveolens, H. orientale, H. plicatum
subsp. plicatum and their methanol extracts were found to be
active against Aeromonas hydrophila, Klebsiella pneumoniae,
P. aeruginosa, Bacillus brevis, B. cereus, B. subtilis, S. aureus,
by the agar-well diffusion method in a previous study. Also
methanol extracts of these species have showed antifungal
activity against C. albicans (Albayrak et al., 2010).
In our previous study the extracts D and E of H. compactum
showed antibacterial and antifungal activity with a MIC value of
40 μg/mL against B. subtilis, S. aureus, E. coli, P. aeruginosa
and C. albicans by the serial dilution method (Süzgeç et al.,
2005).
In this study, extracts B and E from H. chasmolycicum
showed moderate antibacterial and antifungal activity against P.
aeruginosa and the yeast C. albicans, while no activity was
observed against S. aureus and E. coli, K. pneumoniae or P.
mirabilis for any of the extracts. Extract D didn't show
antibacterial activity against any of the organisms tested.
Extract E showed antibacterial activity against P. aeruginosa
with a MIC value of 625 μg/mL. But kaempferol 3-O-glucoside
which is isolated from E extract has no activity against to all
microorganisms tested. The flavonoid glucosides or other
compounds could be responsible for the antimicrobial activity
of extract E.
Both extract B and its major flavonoid compound 3,5-
dihydroxy-6,7,8-trimethoxyflavone showed antifungal activity
against C. albicans with a MIC value of 312 μg/mL. Afolayan
and Meyer (1997) reported that galangin (3,5,7-trihydroxy-
flavone) possessed antimicrobial activity and the antimicrobial
property of galangin might be associated with its lack of
hydroxyl groups on the B ring. Also our study, the antimicrobial
property of 3,5-dihydroxy-6,7,8-trimethoxyflavone might be
associated with its lack of hydroxyl groups on the B ring as
galangin. On the other hand, the other flavonoid compounds
were isolated in a limited amount in H. chasmolycicum and
could not be tested antimicrobial activity in this study.
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